Your browser doesn't support javascript.
loading
Challenges of the Human Proteome Project: 10-Year Experience of the Russian Consortium.
Archakov, Alexander I; Aseev, Alexander L; Bykov, Victor A; Grigoriev, Anatoly I; Govorun, Vadim M; Ilgisonis, Ekaterina V; Ivanov, Yuri D; Ivanov, Vadim T; Kiseleva, Olga I; Kopylov, Arthur T; Lisitsa, Andrey V; Mazurenko, Sergey N; Makarov, Alexander A; Naryzhny, Stanislav N; Pleshakova, Tatiana O; Ponomarenko, Elena A; Poverennaya, Ekaterina V; Pyatnitskii, Mikhail A; Sagdeev, Renad Z; Skryabin, Konstantin G; Zgoda, Victor G.
Afiliação
  • Archakov AI; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Aseev AL; Institute of Semiconductor Physics , Novosibirsk 630090 , Russia.
  • Bykov VA; "NT-MDT" , Moscow 124460 , Russia.
  • Grigoriev AI; Institute of Medical and Biological Problems , Moscow 123007 , Russia.
  • Govorun VM; Federal Research and Clinical Center of Physical-Chemical Medicine , Moscow 119435 , Russia.
  • Ilgisonis EV; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Ivanov YD; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Ivanov VT; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry , Moscow 117997 , Russia.
  • Kiseleva OI; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Kopylov AT; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Lisitsa AV; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Mazurenko SN; Joint Institute for Nuclear Research , Dubna, Moscow region 141980 , Russia.
  • Makarov AA; Engelhardt Institute of Molecular Biology , Moscow 119991 , Russia.
  • Naryzhny SN; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Pleshakova TO; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Ponomarenko EA; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Poverennaya EV; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Pyatnitskii MA; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
  • Sagdeev RZ; International Tomography Center , Novosibirsk 630090 , Russia.
  • Skryabin KG; The Federal Research Centre "Fundamentals of Biotechnology" , Moscow 119071 , Russia.
  • Zgoda VG; Institute of Biomedical Chemistry , Moscow 119435 , Russia.
J Proteome Res ; 18(12): 4206-4214, 2019 12 06.
Article em En | MEDLINE | ID: mdl-31599598
ABSTRACT
This manuscript collects all the efforts of the Russian Consortium, bottlenecks revealed in the course of the C-HPP realization, and ways of their overcoming. One of the main bottlenecks in the C-HPP is the insufficient sensitivity of proteomic technologies, hampering the detection of low- and ultralow-copy number proteins forming the "dark part" of the human proteome. In the frame of MP-Challenge, to increase proteome coverage we suggest an experimental workflow based on a combination of shotgun technology and selected reaction monitoring with two-dimensional alkaline fractionation. Further, to detect proteins that cannot be identified by such technologies, nanotechnologies such as combined atomic force microscopy with molecular fishing and/or nanowire detection may be useful. These technologies provide a powerful tool for single molecule analysis, by analogy with nanopore sequencing during genome analysis. To systematically analyze the functional features of some proteins (CP50 Challenge), we created a mathematical model that predicts the number of proteins differing in amino acid sequence proteoforms. According to our data, we should expect about 100 000 different proteoforms in the liver tissue and a little more in the HepG2 cell line. The variety of proteins forming the whole human proteome significantly exceeds these results due to post-translational modifications (PTMs). As PTMs determine the functional specificity of the protein, we propose using a combination of gene-centric transcriptome-proteomic analysis with preliminary fractionation by two-dimensional electrophoresis to identify chemically modified proteoforms. Despite the complexity of the proposed solutions, such integrative approaches could be fruitful for MP50 and CP50 Challenges in the framework of the C-HPP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Proteoma / Proteômica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: Asia / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas / Proteoma / Proteômica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: Asia / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article